Annovis Bio, Inc. Quarterly Debt-to-equity in % from Q3 2020 to Q2 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Annovis Bio, Inc. quarterly Debt-to-equity history and growth rate from Q3 2020 to Q2 2024.
Annovis Bio, Inc. Debt-to-equity for the quarter ending June 30, 2024 was -637 %, a 3834% decline year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q2 2024	-637	-654	-3834%	Jun 30, 2024
Q1 2024	213	+199	+1433%	Mar 31, 2024
Q4 2023	72.9	+64	+714%	Dec 31, 2023
Q3 2023	24.7	+20.5	+489%	Sep 30, 2023
Q2 2023	17.1	+14	+452%	Jun 30, 2023
Q1 2023	13.9	+11.2	+417%	Mar 31, 2023
Q4 2022	8.96	+5.41	+153%	Dec 31, 2022
Q3 2022	4.19	+0.29	+7.43%	Sep 30, 2022
Q2 2022	3.09	-1.71	-35.7%	Jun 30, 2022
Q1 2022	2.69	-7.66	-74%	Mar 31, 2022
Q4 2021	3.55	-2.73	-43.5%	Dec 31, 2021
Q3 2021	3.9	-17.1	-81.4%	Sep 30, 2021
Q2 2021	4.8			Jun 30, 2021
Q1 2021	10.4			Mar 31, 2021
Q4 2020	6.27			Dec 31, 2020
Q3 2020	21			Sep 30, 2020

* An asterisk sign (*) next to the value indicates that the value is likely invalid.